These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 34511843)

  • 1. Nanotechnology-Based Approach to Combat Pandemic COVID 19: A Review.
    Shukla BK; Tyagi H; Bhandari H; Garg S
    Macromol Symp; 2021 Jun; 397(1):2000336. PubMed ID: 34511843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
    Gudadappanavar AM; Benni J
    J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology based solutions to combat zoonotic viruses with special attention to SARS, MERS, and COVID 19: Detection, protection and medication.
    Ramakrishnan SG; Robert B; Salim A; Ananthan P; Sivaramakrishnan M; Subramaniam S; Natesan S; Suresh R; Rajeshkumar G; Maran JP; Al-Dhabi NA; Karuppiah P; Valan Arasu M
    Microb Pathog; 2021 Oct; 159():105133. PubMed ID: 34390768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosafety and biosecurity approaches to restrain/contain and counter SARS-CoV-2/COVID-19 pandemic: a rapid-review.
    Ahmad T; Haroon ; Dhama K; Sharun K; Khan FM; Ahmed I; Tiwari R; Musa TH; Khan M; Bonilla-Aldana DK; J Rodriguez-Morales A; Hui J
    Turk J Biol; 2020; 44(3):132-145. PubMed ID: 32595350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status.
    Abd El-Aziz TM; Stockand JD
    Infect Genet Evol; 2020 Sep; 83():104327. PubMed ID: 32320825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pipeline Pharmacological Therapies in Clinical Trial for COVID-19 Pandemic: a Recent Update.
    Kumari P; Rawat K; Saha L
    Curr Pharmacol Rep; 2020; 6(5):228-240. PubMed ID: 32837854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2019-2020 Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Pandemic: A Joint American College of Academic International Medicine-World Academic Council of Emergency Medicine Multidisciplinary COVID-19 Working Group Consensus Paper.
    Stawicki SP; Jeanmonod R; Miller AC; Paladino L; Gaieski DF; Yaffee AQ; De Wulf A; Grover J; Papadimos TJ; Bloem C; Galwankar SC; Chauhan V; Firstenberg MS; Di Somma S; Jeanmonod D; Garg SM; Tucci V; Anderson HL; Fatimah L; Worlton TJ; Dubhashi SP; Glaze KS; Sinha S; Opara IN; Yellapu V; Kelkar D; El-Menyar A; Krishnan V; Venkataramanaiah S; Leyfman Y; Saoud Al Thani HA; Wb Nanayakkara P; Nanda S; Cioè-Peña E; Sardesai I; Chandra S; Munasinghe A; Dutta V; Dal Ponte ST; Izurieta R; Asensio JA; Garg M
    J Glob Infect Dis; 2020; 12(2):47-93. PubMed ID: 32773996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How can nanotechnology help to combat COVID-19? Opportunities and urgent need.
    Campos EVR; Pereira AES; de Oliveira JL; Carvalho LB; Guilger-Casagrande M; de Lima R; Fraceto LF
    J Nanobiotechnology; 2020 Sep; 18(1):125. PubMed ID: 32891146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2: Insight in genome structure, pathogenesis and viral receptor binding analysis - An updated review.
    Bhat EA; Khan J; Sajjad N; Ali A; Aldakeel FM; Mateen A; Alqahtani MS; Syed R
    Int Immunopharmacol; 2021 Jun; 95():107493. PubMed ID: 33721758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19).
    Ahn DG; Shin HJ; Kim MH; Lee S; Kim HS; Myoung J; Kim BT; Kim SJ
    J Microbiol Biotechnol; 2020 Mar; 30(3):313-324. PubMed ID: 32238757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoprotection from SARS-COV-2: would nanotechnology help in Personal Protection Equipment (PPE) to control the transmission of COVID-19?
    Phuna ZX; Panda BP; Hawala Shivashekaregowda NK; Madhavan P
    Int J Environ Health Res; 2023 Jul; 33(7):670-699. PubMed ID: 35253535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19.
    Vahedifard F; Chakravarthy K
    Emergent Mater; 2021; 4(1):75-99. PubMed ID: 33615140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomedical application, drug delivery and metabolic pathway of antiviral nanotherapeutics for combating viral pandemic: A review.
    Mukherjee S; Mazumder P; Joshi M; Joshi C; Dalvi SV; Kumar M
    Environ Res; 2020 Dec; 191():110119. PubMed ID: 32846177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentialities of graphene and its allied derivatives to combat against SARS-CoV-2 infection.
    Hashmi A; Nayak V; Singh KR; Jain B; Baid M; Alexis F; Singh AK
    Mater Today Adv; 2022 Mar; 13():100208. PubMed ID: 35039802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insight from nanomaterials and nanotechnology towards COVID-19.
    Singh YD; Ningthoujam R; Panda MK; Jena B; Babu PJ; Mishra AK
    Sens Int; 2021; 2():100099. PubMed ID: 34766056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.
    Gong W; Parkkila S; Wu X; Aspatwar A
    Int Rev Immunol; 2023; 42(6):393-414. PubMed ID: 35635216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and analysis of nucleic acid in various biological samples of COVID-19 patients.
    Wu J; Liu J; Li S; Peng Z; Xiao Z; Wang X; Yan R; Luo J
    Travel Med Infect Dis; 2020; 37():101673. PubMed ID: 32311437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19: A Worldwide, Zoonotic, Pandemic Outbreak.
    Khan T; Agnihotri K; Tripathi A; Mukherjee S; Agnihotri N; Gupta G
    Altern Ther Health Med; 2020 Aug; 26(S2):56-64. PubMed ID: 32412918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling and tracking Covid-19 cases using Big Data analytics on HPCC system platformm.
    Villanustre F; Chala A; Dev R; Xu L; LexisNexis JS; Furht B; Khoshgoftaar T
    J Big Data; 2021; 8(1):33. PubMed ID: 33614394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.